WJWM
VRTX icon

Williams Jones Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Williams Jones Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Buy
1,169
+34
+3% +$15.1K 0.01% 352
2026
Q1 		$507K Sell
1,135
-20
-2% -$9.33K 0.01% 351
2025
Q4 		$524K Buy
1,155
+21
+2% +$9.05K 0.01% 343
2025
Q3 		$444K Hold
1,134
– – 0.01% 363
2025
Q2 		$505K Hold
1,134
– – 0.01% 348
2025
Q1 		$550K Hold
1,134
– – 0.01% 321
2024
Q4 		$457K Sell
1,134
-1
-0.1% -$464 0.01% 358
2024
Q3 		$528K Sell
1,135
-16
-1% -$7.69K 0.01% 352
2024
Q2 		$539K Buy
1,151
+10
+0.9% +$4.34K 0.01% 334
2024
Q1 		$477K Buy
1,141
+100
+10% +$42.3K 0.01% 362
2023
Q4 		$424K Hold
1,041
– – 0.01% 371
2023
Q3 		$362K Buy
1,041
+1
+0.1% +$350 0.01% 392
2023
Q2 		$366K Hold
1,040
– – 0.01% 395
2023
Q1 		$328K Sell
1,040
-2
-0.2% -$600 0.01% 430
2022
Q4 		$301K Buy
1,042
+2
+0.2% +$610 0.01% 441
2022
Q3 		$301K Buy
1,040
+14
+1% +$4.03K 0.01% 441
2022
Q2 		$289K Sell
1,026
-20
-2% -$5.35K ﹤0.01% 462
2022
Q1 		$273K Buy
1,046
+56
+6% +$13.3K ﹤0.01% 433
2021
Q4 		$217K Sell
990
-3,296
-77% -$641K ﹤0.01% 453
2021
Q3 		$777K Sell
4,286
-1,383
-24% -$270K 0.01% 270
2021
Q2 		$1.14M Sell
5,669
-14,849
-72% -$3.11M 0.02% 237
2021
Q1 		$4.41M Sell
20,518
-5,846
-22% -$1.28M 0.07% 146
2020
Q4 		$6.23M Sell
26,364
-27,839
-51% -$6.39M 0.1% 114
2020
Q3 		$14.8M Buy
54,203
+50,968
+1,576% +$14.1M 0.27% 69
2020
Q2 		$939K Buy
3,235
+1,971
+156% +$534K 0.02% 203
2020
Q1 		$301K Buy
1,264
+310
+32% +$71.1K 0.01% 293
2019
Q4 		$209K Buy
+954
New +$193K ﹤0.01% 406

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Williams Jones Wealth Management's VRTX Position: Q2 2026 in Review

Williams Jones Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 3% in Q2 2026, buying an estimated $15.1K and bringing the position to 1,169 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #352.

Williams Jones Wealth Management first reported a position in VRTX in Q4 2019 and has held it in 27 quarters since. The position peaked at $14.8M in Q3 2020. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Williams Jones Wealth Management held 1,169 shares of Vertex Pharmaceuticals worth $581K as of Q2 2026.
  • Williams Jones Wealth Management bought 34 Vertex Pharmaceuticals shares in Q2 2026, an estimated $15.1K.
  • Vertex Pharmaceuticals made up 0.01% of Williams Jones Wealth Management's portfolio in Q2 2026, its #352 holding.
  • Williams Jones Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Williams Jones Wealth Management's Vertex Pharmaceuticals position peaked at $14.8M in Q3 2020.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Williams Jones Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.